IL-31 improves efficacy of macrophage based adoptive cell therapy for cancer

摘要

The present invention provides macrophages genetically modified to express both IL-31 or IL-31 and chimeric antigen receptor (car) for the treatment of cancer. The present invention further provides a method for treating cancer including administering IL-31 with macrophages genetically modified to express unaltered macrophages or cars.No selection